06.12.2017

UK’s NeoPhore pioneers new approach to cancer immunotherapy

Pharmaphorum: Newly launched UK biotech is looking to develop a new approach to immunotherapy, based around a seemingly paradoxical idea that stimulating cancer makes them more visible to the body’s defences.

More news

13.11.2026

NeoPhore strengthens leadership as it prepares to take first-in-class DNA mismatch repair inhibitor into the clinic

Marianne Bjordal appointed CEO; Judit Molnar promoted to Chief Development Officer London, UK, 13 November 2026 – NeoPhore Limited, a company …

21.04.2026

AACR 2026 and AACR Cancer Discovery Article

NeoPhore Press Release: AACR 2026 and AACR Cancer Discovery Article London UK, 21 April 2026 NeoPhore, an immuno-oncology company, announces the …

16.09.2025

NeoPhore's CEO Presents at Morgan Stanley 23rd Annual Global Healthcare Conference | September 2025

NeoPhore's CEO - Michael Shih - recently presented the NeoPhore story at the Morgan Stanley Global Healthcare Conference on Monday September 8th …

Contact us at [email protected]  |  
Call us +44 (0) 330 128 9990